Name
Osaühing Perearstikeskus Remedium
Registry code
12360850
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.10.2012 (12)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86211 - Provision of general medical treatment
31 663 €
61 639 €
195%
2 388 €
(estimate is approximate)
34 611 €
12
Submitted
No tax arrears
178%
51%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Janika Palksaar 02.01.1974 (50) | 33% - 834.00 EUR | Board member | Direct ownership | Founder |
| Natalja Tratš 18.06.1975 (49) | 33% - 833.00 EUR | Board member | Direct ownership | Founder |
| Annika Tamm 14.05.1972 (52) | 33% - 833.00 EUR | Board member | Direct ownership |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tulundusühistu Eesti Ühistukapital 12989447 | - | - | - | Founder |
| 2019 05.07.2020 | 2020 30.06.2021 | 2021 27.06.2022 | 2022 18.06.2023 | 2023 29.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 26 361 € | 21 305 € | 25 182 € | 33 087 € | 31 663 € |
| Net profit (loss) for the period | 67 996 € | 63 044 € | 69 669 € | 74 901 € | 61 639 € |
| Profit Margin | 258% | 296% | 277% | 226% | 195% |
| Current Assets | 59 944 € | 69 939 € | 86 463 € | 97 455 € | 104 323 € |
| Fixed Assets | 26 861 € | 26 295 € | 17 626 € | 8 473 € | 16 373 € |
| Total Assets | 86 805 € | 96 234 € | 104 089 € | 105 928 € | 120 696 € |
| Current Liabilities | 49 210 € | 49 838 € | 51 020 € | 76 504 € | 86 085 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 37 595 € | 46 396 € | 53 069 € | 29 424 € | 34 611 € |
| Employees | 10 | 10 | 11 | 11 | 12 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 54 683.38 € | 51 135.63 € | 9 |
| 2023 Q4 | - | 59 595.08 € | 57 914.52 € | 10 |
| 2023 Q3 | - | 48 612.05 € | 47 936.01 € | 8 |
| 2023 Q2 | - | 42 065.72 € | 40 757.61 € | 9 |
| 2023 Q1 | - | 44 471.82 € | 40 383.81 € | 8 |
| 2022 Q4 | - | 43 677.91 € | 41 187.37 € | 11 |
| 2022 Q3 | - | 44 198.35 € | 41 636.18 € | 11 |
| 2022 Q2 | - | 37 344.68 € | 34 614.15 € | 15 |
| 2022 Q1 | - | 36 012.58 € | 34 913.39 € | 15 |
| 2021 Q4 | - | 42 218.77 € | 39 720.53 € | 15 |
| 2021 Q3 | - | 36 721.46 € | 34 959.48 € | 15 |
| 2021 Q2 | - | 34 095.74 € | 32 819.94 € | 15 |
| 2021 Q1 | - | 34 036.14 € | 32 476.03 € | 16 |
| 2020 Q4 | - | 39 496.89 € | 37 415.37 € | 15 |
| 2020 Q3 | - | 33 132.87 € | 30 877.54 € | 15 |
| 2020 Q2 | - | 29 610.82 € | 29 615.36 € | 15 |
| 2020 Q1 | - | 30 877.31 € | 29 566.13 € | 14 |
